IndiaTickerAnnual Report 2025 - Bafna Pharmaceuticals LimitedBSE · annual report · 147 pages
VerifiedArchived copy Company dossier
Bafna Pharmaceuticals
NSE:BAFNAPH · ISIN INE878I01022
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bafna Pharmaceuticals
Business
Business evidence pack
Source documentsPrimary material for understanding Bafna Pharmaceuticals
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
Financial Year 2012 from bseBSE · annual report · 144 pages
VerifiedArchived copy Financial Year 2015 from bseBSE · annual report · 137 pages
VerifiedArchived copy Financial Year 2013 from bseBSE · annual report · 148 pages
VerifiedArchived copy Financial Year 2014 from bseBSE · annual report · 165 pages
VerifiedArchived copy Financial Year 2019 from bseBSE · annual report · 158 pages
VerifiedArchived copy Financial Year 2024 from bseBSE · annual report · 133 pages
VerifiedArchived copy Financial Year 2021 from bseBSE · annual report · 106 pages
VerifiedArchived copy Financial Year 2017 from bseBSE · annual report · 144 pages
VerifiedArchived copy Financial Year 2025 from bseBSE · annual report · 147 pages
VerifiedArchived copy Financial Year 2022 from bseBSE · annual report · 104 pages
VerifiedArchived copy Financial Year 2016 from bseBSE · annual report · 134 pages
VerifiedArchived copy Financial Year 2018 from bseBSE · annual report · 151 pages
VerifiedArchived copy Financial Year 2023 from bseBSE · annual report · 138 pages
VerifiedArchived copy Financial Year 2020 from bseBSE · annual report · 170 pages
VerifiedArchived copy